$2.70
+0.28 (+11.57%)
Open$2.42
Previous Close$2.42
Day High$2.72
Day Low$2.38
52W High$2.88
52W Low$0.91
Volume—
Avg Volume4.10M
Market Cap217.97M
P/E Ratio—
EPS$-1.09
SectorBiotechnology
Analyst Ratings
Buy
18 analysts
Price Target
+113.0% upside
Current
$2.70
$2.70
Target
$5.75
$5.75
$4.43
$5.75 avg
$6.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.83M | 14.21M | 39.14M |
| Net Income | -119,672,544 | -262,567,746 | -10,010,485 |
| Profit Margin | -2,051.1% | -1,948.5% | -25.6% |
| EBITDA | -118,348,063 | -274,087,420 | -16,322,152 |
| Free Cash Flow | — | — | -10,981,777 |
| Rev Growth | -59.0% | -59.0% | +22.5% |
| Debt/Equity | 0.05 | 0.05 | 0.27 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |